Cigna Corp. Stock

Cigna Group’s fiscal 2025 results present a mixed narrative: robust top-line growth paired with a striking recovery in net income, though much of the profit surge appears to stem from non-operating factors rather than core margin expansion. Revenue rose approximately 11% to $274.9 billion, while net income attributable to shareholders jumped over 73% to $5.96 billion, recovering from a subdued prior year that had been weighed down by substantial investment losses. This rebound, combined with a comfortable cash position, gives the company an air of financial resilience, yet a closer look reveals pressures beneath the surface.

Revenue expansion was driven overwhelmingly by Evernorth Health Services, where pharmacy revenues surged past $216 billion. This segment’s rapid growth, however, carries a lower margin profile, which helps explain the multi-year compression in gross margin—down from 26.2% in 2024 to 21.8% in 2025. Operating margin also edged lower to 3.4%, suggesting that the underlying profitability of the business may be gradually eroding even as revenues climb. The sharp improvement in net margin to 2.2% (from 1.4%) was largely a function of investment portfolio volatility normalizing; net investment losses shrank from $2.7 billion in 2024 to a negligible $24 million in 2025, providing an outsized lift to the bottom line that may not be repeatable.

The balance sheet is marked by a significant intangible asset base—goodwill and other intangibles combine to exceed $73 billion, or nearly half of total assets—reflecting the company’s acquisition history. Despite carrying over $31 billion in total debt, pre‑calculated leverage metrics present a net cash position, implying that liquid assets are ample relative to borrowings; this could afford meaningful financial flexibility. Liquidity ratios remain below 1 (current ratio 0.85, quick ratio 0.72), a common feature for a business that generates large pharmacy-service payables, but one that nonetheless warrants attention if operating cash flows were to weaken.